πŸ‡ΊπŸ‡Έ FDA
Patent

US 8916549

Thienooxazepine derivative

granted A61KA61K31/553A61P

Quick answer

US patent 8916549 (Thienooxazepine derivative) held by Takeda Pharmaceutical Company Limited expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/553, A61P, A61P1/00, A61P1/04